Gabapentin in the treatment of neuropathic pain after spinal cord injury: A prospective, randomized, double-blind, crossover trial

Journal of Spinal Cord Medicine

Volumn 25, Issue 2, 2002, Pages 100-105

  Tai, Qing ^a   Kirshblum, Steven ^a,b   Chen, Boqing ^a   Millis, Scott ^b   Johnston, Mark ^b   DeLisa, Joel A ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b KESSLER INSTITUTE FOR REHABILITATION   (United States)

Author keywords

Gabapentin; Neuropathic pain; Spinal cord injuries

Indexed keywords

GABAPENTIN; 4 AMINOBUTYRIC ACID; ACETIC ACID DERIVATIVE; AMINE; ANALGESIC AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; NEUROPATHIC PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SPINAL CORD INJURY; DOSE RESPONSE; INJURY SCALE; MIDDLE AGED; NEURALGIA; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ACETIC ACIDS; ADULT; AMINES; ANALGESICS; CROSS-OVER STUDIES; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SPINAL CORD INJURIES; TIME FACTORS; TRAUMA SEVERITY INDICES; TREATMENT OUTCOME;

EID: 0036595280     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1080/10790268.2002.11753609     Document Type: Article

References (44)

1. Davis L, Martin J. Studies upon spinal cord injuries. II. The nature and treatment of pain. J Neurosurg. 1947;4:483-491.
2. Botterell E, Callanghan J, Jousse A. Pain in paraplegia-clinical management and surgical treatment. Proc R Soc Med. 1953;47:281-288.
3. Nepomuceno C, Fine PR, Richards JS, et al. Pain in patients with spinal cord injury. Arch Phys Med Rehabil. 1979;60:605-609.
4. Woolsey RM. Chronic pain following spinal cord injury. J Am Paraplegia Soc. 1986;9:39-41.
5. Rose M, Robinson JE, Ells P, Cole JD. Pain following spinal cord injury: Results from a postal survey. Pain. 1988;34:101-102.
6. Britell CW, Mariano AJ. Chronic pain in spinal cord injury. In: Walsh NE, ed. Phys Med Rehabil: State of the Art Reviews. 1991;5(1):72-81, Philadelphia, Pa: Hanley & Belfus, Inc.
7. Cairns DM, Adkins RH, Scott MD. Pain and depression in acute traumatic spinal cord injury: Origins of chronic problematic pain? Arch Phys Med Rehabil. 1996;77:329-335.
8. Rintala DH, Loubser PG, Castro J, Hart KA, Fuhrer MJ. Chronic pain in a community-based sample of men with spinal cord injury: Prevalence, severity, and relationship with impairment, disability, handicap, and subjective well-being. Arch Phys Med Rehabil. 1998; 79:604-614.
9. Siddall PJ, Loeser JD. Pain following spinal cord injury. Spinal Cord. 2001;39:63-73.
10. Galer BS, Jensen MO. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology. 1997;48:332-339.
11. Ragnarsson KT. Management of pain in persons with spinal cord injury. J Spinal Cord Med. 1997;20:186-199.
12. Tunks E. Pain in spinal cord injured patients. In: Bloch RF, Basbaum M, eds. Management of Spinal Cord Injuries. Baltimore, Md: Williams & Wilkins; 1986:180-211.
13. Yaksh TL. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain. 1989;37:111-123.
14. Davidoff G, Roth E. Clinical characteristics of central (dysesthetic) pain in spinal cord injury patients. In: Casey KL, ed. Pain and Central Nervous System Disease: The Central Pain Syndromes. New York: Raven Press; 1991:77-83.
15. Beric A. Pain in spinal cord injury. In: Illis LS, ed. Spinal Cord Dysfunction. Vol. II. New York: University Press; 1992:156-165.
16. Hao JX, Xu XJ, Yu YX, Seiger A, Wiesenfeld-Hallin Z. Baclofen reverses the hypersensitivity of dorsal horn wide dynamic range neurons to mechanical stimulation after transient spinal cord ischemia: implications for a tonic GABAergic inhibitory control of myelinated fiber input. Neurophysiology. 1992;68:392-396.
17. Boivie J., Central pain. In: Wall PD, Melzack R, eds. Textbook of Pain, 3rd ed. New York: Churchill Livingstone; 1994:871-902.
18. Hao JX, Xu XJ, Wiesenfeld-Hallin Z. Intrathecal r-aminobutyric acidB (GABAB) receptor antagonist CGP 35348 induces hypersensitivity to mechanical stimuli in the rat. Neurosci Lett. 1994;182:299-302.
19. Zhang AL, Hao JX, Seiger A, et al. Decreased GABA immunoreactivity in spinal cord dorsal horn neurons after transient spinal cord ischemia in the rat. Brain Res. 1994;656:187-190.
20. Yezierski RP. Pain following spinal cord injury: the clinical problem and experimental studies. Pain. 1996;68:185-194.
21. Yezierski RP. Pain following spinal cord injury: pathophysiology and central mechanisms [review]. Prog Brain Res. 2000;429-449.
22. Vollmer KO, Von Hodenberg A, Kolle EU. Pharmacokinetics and metabolism of gabapentin in rat, dog, and men. Arzneimittelforschung. 1986;36:830-839.
23. Gao KL, Sorkin EM. Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy. Drug. 1993;46:409-427.
24. Gotz E, Feuerstein TJ, Lais A, Meyer DK. Effects of gabapentin on release of r-aminobutyric acid from slices of rat neostriatum. Arzneimittelforschung. 1993;43:636-638.
25. Petroff OAC, Rothman DL, Behar KL, Lamoureux D, Mattson RH. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol. 1996;39:95-99.
26. Bryans JS, Davies N, Gee NS, et al. Identification of novel ligands for the gabapentin binding site on the alpha2 delta subunits of a calcium channel and their evaluation as anticonvulsant agents. J Med Chem. 1998;41:1838-1845.
27. Stefani A, Spadoni F, Bernardi G. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology. 1998; 37:83-91.
28. Field MJ, Hughes J, Singh L. Further evidence for the role of the alpha(2) delta subunit voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol. 2000;131:282-286.
29. Taylor CP, Gee NS, Su TZ, et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 1998;29:233-249.
30. Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain. 1996;12:56-58.
31. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280: 1831-1836.
32. Segal AZ, Rordorf G. Gabapentin as a novel treatment for postherpetic neuralgia. Neurology. 1996;46:1175-1176.
33. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Milleret L. Gabapentin for the treatment of postherpetic neuralgia. JAMA. 1998;280:1837-1842.
34. Mellick GA, Mellicy LB, Mellick LB. Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Manage. 1995; 10:265-266.
35. McEvoy G, ed. Gabapentin. AHFS Drug Information. Bethesda, Md: American Society of Health System Pharmacists; 1999:1875-1877.
36. Ness TJ, San Pedro EC, Richards JS, et al. A case of spinal cord injury-related pain with baseline rCBF brain SPECT imaging and beneficial response to gabapentin. Pain. 1998;78:139-143.
37. Salas MM, Barber DB, Rogers SJ, Able AC, Fredrickson MD. Gabapentin and neuropathic pain in spinal cord injury: A retrospective study [abstract]. J Spinal Cord Med. 1999;22:364.
38. Kapadia NP, Harden N. Gabapentin for chronic pain in spinal cord injury: a case report. Arch Phys Med Rehabil. 2000;81:1439-1441.
39. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment. New York: Guilford Press; 1992:135-151.
40. Price DD, Harkins SW. Psychophysical approaches to pain measurement and assessment. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment. New York: Guilford Press; 1992:111-134.
41. Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain. 1975;1:277-299.
42. Melzack R, Katz J. The McGill Pain Questionnaire: appraisal and current status. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment. New York: Guilford Press; 1992:152-168.
43. Gracely RH, McGrath P, Dubner R. Ratio scales of sensory and affective verbal pain descriptors. Pain. 1978;5:5-18.
44. Galer BS, Dworkin RH. A Clinical Guide to Neuropathic Pain. Minneapolis, Minn: Healthcare Information Programs, a Division of McGraw-Hill Healthcare Information; 2000.